开云app官网登录入口网页版-官方正版

#拉米夫定#

6篇内容 | 986人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2218547, encodeId=8b31221854ea3, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a> <a href='/topic/show?id=877011155123' target=_blank style='color:#2F92EE;'>#逆转录转座子#</a> <a href='/topic/show?id=f4ab11e55328' target=_blank style='color:#2F92EE;'>#晚发性阿尔茨海默病#</a>, objectTitle=皮肤细胞变身神经元！Science：科学家利用细胞重编程技术，成功构建出研究晚发性阿尔茨海默病的体外模型, objectType=article, longId=837412, objectId=917b83e41299, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240803/1722644884658_2185383.png, objectUrl=/article/show_article.do?id=917b83e41299, replyNumber=0, likeNumber=20, createdTime=2024-08-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1627031, encodeId=bcf2162e03148, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案, objectType=article, longId=153251, objectId=cb4915325177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb4915325177, replyNumber=0, likeNumber=61, createdTime=2018-11-12, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb4915325177, moduleTitle=Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cb4915325177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627030, encodeId=6e71162e030ca, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=Pharmaceut Res:茚地那韦部分通过抑制多药和毒素排出蛋白1（MATE1）改变拉米夫定的药代动力学, objectType=article, longId=125692, objectId=336a1256926c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=336a1256926c, replyNumber=0, likeNumber=78, createdTime=2018-01-07, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=336a1256926c, moduleTitle=Pharmaceut Res:茚地那韦部分通过抑制多药和毒素排出蛋白1（MATE1）改变拉米夫定的药代动力学, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=336a1256926c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627029, encodeId=954d162e029a3, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=J Hepatol：拉米夫定耐药的乙肝治疗：TDF vs FTC/TDF, objectType=article, longId=77208, objectId=343ee7208cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343ee7208cf, replyNumber=0, likeNumber=68, createdTime=2016-09-13, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343ee7208cf, moduleTitle=J Hepatol：拉米夫定耐药的乙肝治疗：TDF vs FTC/TDF, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=343ee7208cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627028, encodeId=fddc162e028c6, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=Lancet：洛匹那韦–利托那韦加上拉米夫定对HIV-1病毒抑制的维持, objectType=article, longId=51817, objectId=9fec5181e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fec5181e83, replyNumber=0, likeNumber=63, createdTime=2015-06-10, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fec5181e83, moduleTitle=Lancet：洛匹那韦–利托那韦加上拉米夫定对HIV-1病毒抑制的维持, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9fec5181e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627027, encodeId=5b5a162e027fe, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=JAMA：预防淋巴瘤化疗患者乙肝复发，恩替卡韦or拉米夫定？, objectType=article, longId=44474, objectId=64a7444e472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64a7444e472, replyNumber=0, likeNumber=66, createdTime=2014-12-24, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64a7444e472, moduleTitle=JAMA：预防淋巴瘤化疗患者乙肝复发，恩替卡韦or拉米夫定？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=64a7444e472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627026, encodeId=0bdf162e02605, content=<a href='/topic/show?id=ce0b561568c' target=_blank style='color:#2F92EE;'>#拉米夫定#</a>, objectTitle=13名埃博拉患者服抗艾药拉米夫定获救, objectType=article, longId=40881, objectId=3dc64088114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc64088114, replyNumber=0, likeNumber=67, createdTime=2014-10-04, rootId=0, userName=jj000008, userId=aacc21077985, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc64088114, moduleTitle=13名埃博拉患者服抗艾药拉米夫定获救, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3dc64088114)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

拉米夫定

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#拉米夫定# #逆转录转座子# #晚发性阿尔茨海默病#

2024-08-05发表于上海

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案

2018-11-12

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

Pharmaceut Res:茚地那韦部分通过抑制多药和毒素排出蛋白1（MATE1）改变拉米夫定的药代动力学

2018-01-07

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

J Hepatol：拉米夫定耐药的乙肝治疗：TDF vs FTC/TDF

2016-09-13

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

Lancet：洛匹那韦–利托那韦加上拉米夫定对HIV-1病毒抑制的维持

2015-06-10

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

JAMA：预防淋巴瘤化疗患者乙肝复发，恩替卡韦or拉米夫定？

2014-12-24

jj000008 (审核中...)

前往app查看评论内容

#拉米夫定#

13名埃博拉患者服抗艾药拉米夫定获救

2014-10-04

科室
- - 订阅+
  - 更多科室
工具
服务